Expect to start with 10-12% share of US market for Omega-3 from Day 1: Shashank Sinha, Strides Shasun

Talking to ET Now, Shashank Sinha, MD, Strides Shasun, says the marketing arrangement they have stitched up for the US market gives them the right to market the product through one of the market leaders. Edited excerpts: ET Now: You have received the USFDA nod for a key drug.

You can read more here: Expect to start with 10-12% share of US market for Omega-3 from Day 1: Shashank Sinha, Strides Shasun